AstraZeneca beats profit estimates, backs 2026 outlook on strong cancer drug sales - Reuters

Reuters | April 29, 2026, 4:33 a.m. | Original
AstraZeneca beats profit estimates, backs 2026 outlook on strong cancer drug sales Reuters
Amadeus to buy French biometrics firm Idemia for 1.2 billion euros - Reuters Cognizant to buy Astreya for about $600 million - Reuters